Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 22147715)

1.

Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Ann Intern Med. 2011 Dec 6;155(11):772-85. doi: 10.7326/0003-4819-155-11-201112060-00009. Review.

PMID:
22147715
2.

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.

PMID:
19017592
3.

Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.

Reichenpfader U, Gartlehner G, Morgan LC, Greenblatt A, Nussbaumer B, Hansen RA, Van Noord M, Lux L, Gaynes BN.

Drug Saf. 2014 Jan;37(1):19-31. doi: 10.1007/s40264-013-0129-4. Review.

PMID:
24338044
4.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
5.

Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.

Nussbaumer B, Morgan LC, Reichenpfader U, Greenblatt A, Hansen RA, Van Noord M, Lux L, Gaynes BN, Gartlehner G.

CNS Drugs. 2014 Aug;28(8):699-712. doi: 10.1007/s40263-014-0169-z. Review.

PMID:
24794101
6.

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE, Lohr KN.

Drug Saf. 2008;31(10):851-65. Review.

PMID:
18759509
7.

The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis.

Gartlehner G, Thaler K, Hansen RA, Gaynes BN.

Drug Saf. 2009;32(12):1159-73. doi: 10.2165/11318930-000000000-00000. Review.

PMID:
19916583
8.

Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.

Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS.

Ann Intern Med. 2012 Oct 2;157(7):498-511. Review.

PMID:
22893011
9.

Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.

Maneeton N, Maneeton B, Eurviriyanukul K, Srisurapanont M.

Drug Des Devel Ther. 2013 Sep 27;7:1053-62. doi: 10.2147/DDDT.S46849. eCollection 2013. Review.

10.

Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

Thaler KJ, Morgan LC, Van Noord M, Gaynes BN, Hansen RA, Lux LJ, Krebs EE, Lohr KN, Gartlehner G.

Depress Anxiety. 2012 Jun;29(6):495-505. doi: 10.1002/da.21951. Epub 2012 May 2. Review.

PMID:
22553134
11.

Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].

Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Gaynes BN, Thieda P, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec.

12.

Second-generation antidepressants for seasonal affective disorder.

Thaler K, Delivuk M, Chapman A, Gaynes BN, Kaminski A, Gartlehner G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008591. doi: 10.1002/14651858.CD008591.pub2. Review.

PMID:
22161433
13.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

JAMA. 2007 Apr 18;297(15):1683-96.

PMID:
17440145
14.

Treatment of depression--newer pharmacotherapies.

Mulrow CD, Williams JW Jr, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.

Psychopharmacol Bull. 1998;34(4):409-795. Review.

PMID:
10513454
15.

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.

Hansen R, Gaynes B, Thieda P, Gartlehner G, Deveaugh-Geiss A, Krebs E, Lohr K.

Psychiatr Serv. 2008 Oct;59(10):1121-30. doi: 10.1176/appi.ps.59.10.1121.

16.

Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents.

Kaminski A, Kamper A, Thaler K, Chapman A, Gartlehner G.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008013. doi: 10.1002/14651858.CD008013.pub2. Review.

PMID:
21735420
17.

Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK; Clinical Efficacy Assessment Subcommittee of American College of Physicians.

Ann Intern Med. 2008 Nov 18;149(10):725-33. Erratum in: Ann Intern Med. 2009 Jan 20;150(2):148.

PMID:
19017591
18.
19.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
20.

Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.

Nelson JC, Delucchi K, Schneider LS.

Am J Geriatr Psychiatry. 2008 Jul;16(7):558-67. doi: 10.1097/JGP.0b013e3181693288. Review.

PMID:
18591576
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk